K · As filed with the SEC
Kellanova cash flow statement, by fiscal year
The statement as Kellanova presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENT OF CASH FLOWS · USD millions
| USD millions | FY2024 Year ended Dec 28, 2024 | FY2023 Year ended Dec 30, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Jan 1, 2022 | FY2020 Year ended Jan 2, 2021 | FY2019 Year ended Dec 28, 2019 | FY2018 Year ended Dec 29, 2018 | FY2017 Year ended Dec 30, 2017 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net income | 1,356 | 964 | 962 | 1,495 | 1,264 | 977 | 1,344 | 1,254 |
| Adjustments to reconcile net income to operating cash flows | ||||||||
| Depreciation and amortization | 367 | 419 | 478 | 467 | 479 | 484 | 516 | 481 |
| Impairment of property | 60 | — | — | — | — | — | — | — |
| Postretirement benefit plan expense (benefit) | (11) | 53 | 240 | (392) | (77) | (89) | 170 | (427) |
| Deferred income taxes | 24 | (21) | (46) | 125 | 69 | 47 | 46 | (58) |
| Stock compensation | 89 | 95 | 96 | 68 | 76 | 56 | 59 | 66 |
| Multi-employer pension plan exit liability | — | — | — | 0 | (5) | 132 | 7 | 26 |
| Gain from unconsolidated entities, net | — | — | — | — | 0 | 0 | (200) | 0 |
| Noncurrent income taxes payable | — | — | — | — | — | (35) | (23) | 144 |
| Loss on Russia divestiture | 0 | 113 | — | — | — | — | — | — |
| Other | (64) | 40 | (42) | (44) | (16) | (1) | (70) | 1 |
| Postretirement benefit plan distributions | 175 | — | — | — | — | — | — | — |
| Tax payment related to divestitures | — | — | — | 0 | 0 | (255) | 0 | 0 |
| Postretirement benefit plan contributions | (55) | (42) | (23) | (20) | (32) | (28) | (287) | (44) |
| Changes in operating assets and liabilities, net of acquisitions and divestitures: | ||||||||
| Trade receivables | (104) | (42) | (257) | (9) | 75 | (145) | 76 | (1,300) |
| Inventories | 2 | 139 | (411) | (135) | (54) | 2 | (86) | 80 |
| Accounts payable | 38 | (340) | 411 | 194 | (9) | (9) | 115 | 193 |
| All other current assets and liabilities | (117) | 267 | 243 | (48) | 216 | 40 | (154) | (13) |
| Net cash provided by (used in) operating activities | 1,760 | 1,645 | 1,651 | 1,701 | 1,986 | 1,176 | 1,536 | 403 |
| Investing activities | ||||||||
| Additions to properties | (628) | (677) | (488) | (553) | (505) | (586) | (578) | (501) |
| Collections of deferred purchase price on securitized trade receivables | — | — | — | — | — | 0 | 0 | 1,243 |
| Issuance of notes receivable | 0 | (4) | (22) | (28) | — | — | — | — |
| Repayments from notes receivable | 0 | 0 | 10 | 28 | — | — | — | — |
| Acquisitions, net of cash acquired | — | — | — | — | 0 | (8) | (28) | (592) |
| Divestiture, net of cash disposed | — | — | — | 0 | (7) | 1,332 | 0 | 0 |
| Purchases of marketable securities | (350) | — | 0 | 0 | (250) | — | 0 | — |
| Sales of marketable securities | 209 | — | 0 | 0 | 250 | — | 0 | — |
| Settlement of net investment hedges | (7) | 68 | 37 | — | — | — | — | — |
| Investments in unconsolidated entities | — | 0 | 0 | (10) | 0 | 0 | (389) | 0 |
| Acquisition of cost method investments | — | — | — | — | (4) | (1) | (8) | (7) |
| Purchases of available for sale securities | 0 | (15) | (17) | (61) | (81) | (18) | 0 | 0 |
| Sales of available for sale securities | 0 | 64 | 19 | 72 | 19 | 83 | 0 | 0 |
| Other | 26 | 2 | 13 | 24 | (7) | (28) | 55 | 6 |
| Net cash provided by (used in) investing activities | (750) | (562) | (448) | (528) | (585) | 774 | (948) | 149 |
| Financing activities | ||||||||
| Net increase (reduction) of notes payable, with maturities less than or equal to 90 days | (27) | (356) | 337 | (27) | (16) | (18) | (264) | 153 |
| Issuances of notes payable, with maturities greater than 90 days | 27 | 35 | 28 | 73 | 44 | 62 | 62 | 17 |
| Reductions of notes payable, with maturities greater than 90 days | 0 | (25) | (35) | (63) | (34) | (69) | (23) | (238) |
| Issuances of long-term debt | 619 | 404 | 39 | 361 | 557 | 80 | 993 | 1,251 |
| Reductions of long-term debt | (655) | (780) | (648) | (650) | (1,229) | (1,009) | (408) | (632) |
| Debt redemption costs | — | — | 0 | 0 | (20) | (17) | 0 | 0 |
| Net issuances of common stock | 213 | 60 | 277 | 63 | 112 | 64 | 167 | 97 |
| Common stock repurchases | 0 | (170) | (300) | (240) | 0 | (220) | (320) | (516) |
| Cash dividends | (776) | (800) | (797) | (788) | (782) | (769) | (762) | (736) |
| Collateral received on derivative instruments | — | — | — | — | (19) | — | 0 | — |
| Proceeds received from debt issued and retained by WK Kellogg Co | 0 | 663 | — | — | — | — | — | — |
| Cash retained by WK Kellogg Co at separation | 0 | (78) | — | — | — | — | — | — |
| Other | (8) | (63) | 18 | (35) | (1) | (9) | (11) | 0 |
| Net cash provided by (used in) financing activities | (607) | (1,110) | (1,081) | (1,306) | (1,388) | (1,905) | (566) | (604) |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | (16) | 25 | 31 | 18 | 53 |
| Increase (decrease) in cash and cash equivalents | — | — | — | — | — | 76 | 40 | 1 |
| Effect of exchange rate changes on cash and cash equivalents | 17 | 2 | (109) | — | — | — | — | — |
| Increase (decrease) in cash and cash equivalents | 420 | (25) | 13 | (149) | 38 | — | 40 | — |
| Cash and cash equivalents at beginning of period | — | — | 286 | 435 | 397 | 321 | 281 | 280 |
| Cash and cash equivalents at end of period | — | — | — | 286 | 435 | 397 | 321 | 281 |
| Cash and cash equivalents at beginning of period | 274 | 299 | 286 | 435 | — | — | — | — |
| Cash and cash equivalents at end of period | 694 | 274 | 299 | — | — | — | — | — |
| Supplemental cash flow disclosures: | ||||||||
| Interest paid | 303 | 291 | 220 | 213 | 249 | 284 | 280 | 258 |
| Income taxes paid | 244 | 322 | 312 | 365 | 281 | 537 | 188 | 352 |
| Supplemental cash flow disclosures of non-cash investing activities: | ||||||||
| Beneficial interests obtained in exchange for securitized trade receivables | — | — | — | — | — | 0 | 0 | 1,222 |
| Additions to properties included in accounts payable | 142 | 138 | 209 | 162 | 189 | 128 | 162 | 151 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.